Viewing Study NCT00833560


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-27 @ 10:50 PM
Study NCT ID: NCT00833560
Status: COMPLETED
Last Update Posted: 2014-11-21
First Post: 2009-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
Sponsor: Janssen-Cilag G.m.b.H
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR005242
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators